DHS more than doubles revenue

Article

Imaging services provider Diagnostic Health Services of Dallas reported that it enjoyed revenue growth for 1997 (end-December) that was 119% higher than sales in 1996. DHS recorded sales of $59.9 million in 1997, compared with $24.2 million the year

Imaging services provider Diagnostic Health Services of Dallas reported that it enjoyed revenue growth for 1997 (end-December) that was 119% higher than sales in 1996. DHS recorded sales of $59.9 million in 1997, compared with $24.2 million the year before. Net income also grew sharply, to $5.4 million, compared with $2.5 million in 1996.

DHS experienced strong internal growth in 1997, and also completed seven acquisitions during the year, according to chairman and CEO Max Batzer. The firm has continued on its acquisition bent in the first quarter of 1998, buying two companies and signing an agreement to acquire a 50% interest in a California imaging center. The two acquisitions were International Cardiac Monitoring, a Houston-based cardiac event monitoring business, and Sonomed, a mobile ultrasound provider based in Birmingham, AL. The California imaging center is on the campus of Scripps Hospital in Chula Vista, and buying the joint interest will broaden Diagnostic Health's hospital-based MRI operations.

Recent Videos
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
Related Content
© 2025 MJH Life Sciences

All rights reserved.